The global papaverine hydrochloride injection market is anticipated to grow at a significant CAGR during the forecast period. The increase in cases of heart-related disease, growing aging population, and erectile dysfunction are the major factors that are expected to accelerate the market growth during the forecast period. Papaverine Hydrochloride appears as white crystals or white crystalline powder. It is labeled with USP and is not approved by the FDA. This injection is available in packages of 30 mL and in 120 mL and is used for treating spasms of smooth muscle, angina pectoris, peripheral and pulmonary embolism, peripheral vascular disease, or certain cerebral antispastic states, visceral spasm, and erectile dysfunction.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/papaverine-hydrochloride-injection-market
According to the Massachusetts Male Aging Study, the prevalence of erectile dysfunction (ED) is reported as 52% in the US. The study revealed that ED is progressively dominant with age. Approximately 40% of men are affected at age 40. Furthermore, according to the Massachusetts study data, there will be approximately 17,781 new cases of ED in Massachusetts and 617,715 in the US annually. This, in turn, is expected to further accelerate the demand for papaverine which is injected into the penis as it increases the blood flow to the penis, resulting in an erection.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segment Covered
- Regions Covered- Globally
Competitive Landscape: Sandoz International GmbH, and Chengdu Brilliant Pharmaceutical Group, among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominates the market in base year?
- Which segment and region will project fastest growth in the market?
- How COVID-19 impacted the market?
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Papaverine Hydrochloride Injection Market Report by Segment
By Type
- 30 mg/mL,
- 120 mg/10 mL
By Application
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
A full report of Papaverine Hydrochloride Injection Market is available at: https://www.omrglobal.com/industry-reports/papaverine-hydrochloride-injection-market
Papaverine Hydrochloride Injection Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Sandoz International GmbH
- Chengdu Brilliant Pharmaceutical Group
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
